How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Natalie Harb
Advertisement
Is vice president, offering development within IQVIA’S global commerce offering business responsible for global launch excellence. Over the past 25 years, she has worked with some of the world’s most successful brands across both the pharma and CPG industries in Europe, the Americas, and Southeast Asia.
Articles by Natalie Harb
Advertisement
Latest Updated Articles
The Future of Launch Excellence is Generative AIAugust 15th 2024
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5